BioSpace News Archive

Job Trends

Atlanta Poised to Become Biopharma Hot Spot as New Developments Add 80k+ Jobs

Two new developments for lab and office space are expected to add over 2,000 acres of space in Atlanta to accommodate the life science industry’s rapid growth.

May 16, 2023
·
3 min read
·
Rosemary Scott
Policy

Supreme Court Denies Teva’s Challenge to $235M GSK Award in Patent Dispute

The U.S. Supreme Court’s denial of Teva Pharmaceuticals’ appeal could have broad ramifications for the wider generics industry, for which “skinny labeling” is a common and accepted practice.

May 16, 2023
·
2 min read
·
Tristan Manalac
Business

Astellas, Sony Team on Novel ADC Platform for Oncology

A collaborative research agreement will leverage Sony’s unique polymer, which the companies contend is a stable, effective linker for delivering antibody-drug conjugate payloads to cancer cells.

May 16, 2023
·
2 min read
·
Kate Goodwin
Drug Development

Viking Therapeutics Clears Mid-Stage NASH Trial

Results from Phase IIb VOYAGE study showed Viking’s oral thyroid beta receptor agonist cut liver fat content by up to 51% in confirmed non-alcoholic steatohepatitis patients.

May 16, 2023
·
2 min read
·
Tristan Manalac
Policy

Amgen ‘Remains Committed’ to $27.8B Horizon Acquisition After FTC Challenge

The Federal Trade Commission filed a lawsuit Tuesday seeking an injunction to prevent Amgen’s buyout of Horizon Therapeutics, which the agency says would “entrench monopoly drugs.”

May 16, 2023
·
3 min read
·
Heather McKenzie
Poxel Announces Notice of Its Annual General Meeting to Be Held on June 21, 2023

POXEL SA announces the publication of the meeting notice for the Annual General Meeting, which will be held on June 21, 2023 at 9 am CEST at the Mercure Hotel, Lyon Centre Saxe Lafayette, 29 rue de Bonnel, 69003 LYON, France.

May 16, 2023
·
2 min read
Business

Sony and Astellas Enter into Collaborative Research Agreement to Discover a Novel ADC Platform for the Oncology Field

Sony Corporation and Astellas Pharma Inc. announced that they have entered into a collaborative research agreement to discover a novel Antibody-Drug Conjugate platform in oncology based on Sony’s unique polymeric material, “KIRAVIA™ Backbone.”

May 16, 2023
·
6 min read
Drug Development

RadioMedix and Orano Med Complete Patient Enrolment in Phase II Trial of Targeted Alpha-Emitter AlphaMedix in Neuroendocrine Cancers

RadioMedix and Orano Med, two clinical stage radiopharmaceutical companies, announced that the last patient has been dosed in the Phase II trial of the targeted alpha emitter therapy, 212Pb-DOTAMTATE.

May 16, 2023
·
5 min read
Business

Former U.S. White House Surgeon and FDA Medical Officer joins Bioretec team

Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, announces that Dr. Jeremy Dublon joins the Bioretec team to support Company’s U.S. commercialization strategy from a clinical and regulatory perspective.

May 16, 2023
·
2 min read
AlzeCure Participates at Penser Market on May 25

AlzeCure Pharma AB announced that the company is participating at Penser Market on May 25 at 14:05 CET, where CEO Martin Jönsson will present and answer questions about the latest development in the company.

May 16, 2023
·
2 min read